- Home
- MTVA vs ANY Comparison
MTVA vs ANY Comparison
Compare MTVA & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- ANY
- Stock Information
- Founded
- MTVA 2014
- ANY N/A
- Country
- MTVA United States
- ANY United States
- Employees
- MTVA N/A
- ANY N/A
- Industry
- MTVA
- ANY Finance: Consumer Services
- Sector
- MTVA
- ANY Finance
- Exchange
- MTVA NYSE
- ANY Nasdaq
- Market Cap
- MTVA 14.3M
- ANY 15.7M
- IPO Year
- MTVA N/A
- ANY N/A
- Fundamental
- Price
- MTVA $0.71
- ANY $0.66
- Analyst Decision
- MTVA Strong Buy
- ANY Strong Buy
- Analyst Count
- MTVA 2
- ANY 1
- Target Price
- MTVA $7.50
- ANY $3.00
- AVG Volume (30 Days)
- MTVA 64.8K
- ANY 1.3M
- Earning Date
- MTVA 08-13-2025
- ANY 08-12-2025
- Dividend Yield
- MTVA N/A
- ANY N/A
- EPS Growth
- MTVA N/A
- ANY N/A
- EPS
- MTVA N/A
- ANY N/A
- Revenue
- MTVA N/A
- ANY $12,479,000.00
- Revenue This Year
- MTVA N/A
- ANY N/A
- Revenue Next Year
- MTVA N/A
- ANY N/A
- P/E Ratio
- MTVA N/A
- ANY N/A
- Revenue Growth
- MTVA N/A
- ANY N/A
- 52 Week Low
- MTVA $0.60
- ANY $0.36
- 52 Week High
- MTVA $4.36
- ANY $1.90
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- ANY 48.69
- Support Level
- MTVA N/A
- ANY $0.64
- Resistance Level
- MTVA N/A
- ANY $0.74
- Average True Range (ATR)
- MTVA 0.00
- ANY 0.08
- MACD
- MTVA 0.00
- ANY 0.00
- Stochastic Oscillator
- MTVA 0.00
- ANY 28.89
About MTVA METAVIA INC
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
About ANY Sphere 3D Corp.
Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.